Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide is a protein-based molecule, technically a peptide, but it is not a dietary protein in any sense that affects how you eat or what you digest. It is a synthetic analogue of a gut hormone called GLP-1, engineered to resist the rapid breakdown that ordinary peptides face in the body. That structural fact has real-world implications for anyone wondering why protein intake still matters so much during treatment, and the answer is reassuringly straightforward once you separate the chemistry from the confusion. Semaglutide works as a prescription medicine licensed in the UK for weight management under the brand name Wegovy; whether it is right for you is a clinical decision made by a prescriber, not something you can judge from its molecular classification alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A reasonable number of people come across the word 'peptide' on a semaglutide information page and assume the medicine is somehow related to the protein powders sold in gyms or health shops. It is a forgivable leap, and an entirely wrong one. Semaglutide is a synthetic peptide, yes, meaning its backbone is a chain of amino acids like any protein, but that is where the similarity to a chicken breast or a scoop of whey ends. It is manufactured to bind to GLP-1 receptors in your gut, pancreas and brain, slowing gastric emptying and signalling fullness. It arrives in your body via a subcutaneous injection or a tablet, acts on specific receptors in vanishingly small doses, and is broken down by peptidases in tissues, not in the digestive tract the way food proteins are. Thinking of it as a protein supplement would be like calling insulin a snack because it is also a peptide hormone. The biochemistry is adjacent; the function is entirely different. Wegovy's mechanism and licensed uses in the UK are covered in detail if you want a broader picture of how the medicine works.
Here is the practical consequence of semaglutide being a receptor agonist rather than a nutrient: it does not provide protein to your muscles, and it does suppress your appetite substantially. Clinical trials showed average reductions of around 15 per cent of body weight over 68 weeks in participants using semaglutide 2.4mg, as published in the STEP 1 trial in the New England Journal of Medicine. When you lose weight that quickly and your appetite is blunted, muscle tissue is at risk of being broken down alongside fat if dietary protein is insufficient. The medicine does not know whether the weight it is helping you shed is fat or lean mass. That distinction is left to what you eat. Most adults on GLP-1 treatment need somewhere in the region of 1.2 to 1.6 grams of protein per kilogram of body weight per day, though your prescriber or a dietitian should confirm a personal figure. If you want to understand how protein and Wegovy work together to support muscle retention during treatment, it is worth reading before adjusting what you eat. If you are finding it hard to hit that with whole foods because your appetite has dropped considerably, protein shakes alongside Wegovy are worth understanding before you dismiss or overuse them. The short version: semaglutide's own peptide structure contributes nothing to this requirement.
Standard GLP-1, the natural hormone semaglutide mimics, is destroyed by an enzyme called DPP-4 within minutes of release. Semaglutide is engineered to last a week. Novo Nordisk achieved this partly by attaching a long fatty acid chain that binds albumin in the bloodstream, and partly by substituting one amino acid at position 8 to block the DPP-4 cleavage site. The oral Wegovy tablet adds a further layer of ingenuity: the absorption enhancer SNAC protects the peptide from digestive enzymes long enough for it to cross the stomach wall. None of this structural complexity changes its classification as a Prescription-Only Medicine. The NHS semaglutide medicines page sets out the licensed uses and safety information clearly. Understanding that semaglutide is a carefully engineered peptide, rather than a naturally occurring dietary protein, also explains why you cannot meaningfully raise or lower its effect by eating more or less protein at meals. The two systems operate independently. What you eat shapes your muscle retention and satiety alongside the medicine; it does not interact with semaglutide's receptor binding in any direct way.
Knowing semaglutide is a peptide, not a dietary protein, should shift the question from 'does the medicine count towards my protein intake?' (it does not) to 'how do I get enough protein when I am not very hungry?' That is a more useful question, and one our prescribers hear regularly. The practical answer involves front-loading protein at the start of meals before appetite fades, choosing protein-dense foods that are easy to prepare when cooking feels like effort, and monitoring how much you are actually eating rather than guessing. A protein calculator for people on Wegovy can help turn the general guidance into a daily target. For a broader guide to eating well during treatment, what to eat on Wegovy covers the full picture from meal timing to food choices. If you are finding your appetite so suppressed that eating anything feels difficult, that is worth raising with your prescriber rather than pushing through; whether to force yourself to eat on semaglutide is addressed directly in a separate guide. Wegovy is a prescription medicine, and getting the diet right alongside it is part of clinical care, not an afterthought. If you are thinking about starting treatment, a free consultation with our prescribers is the right first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.